16 August 2024
Latham & Watkins Advises on ANI Pharmaceuticals’ Upsized US$316.25 Million Convertible Senior Notes Offering
Advising firms
Deal team
24 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Greg Rodgers Lead | Latham & Watkins LLP | Partner | capital markets | New York/Los Angeles |
| Arash Aminian Baghai Lead | Latham & Watkins LLP | Partner | capital markets | Los Angeles |
| Brent Epstein Lead | Latham & Watkins LLP | Partner | capital markets | Century City |
| Andrew Bentz | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Eric Finkelberg | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Dylan Shamoon | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Reza Mojtabaee-Zamani | Latham & Watkins LLP | Partner | equity derivatives | New York |
| Kevin Zhang | Latham & Watkins LLP | Associate | equity derivatives | Not stated |
| Elena Romanova | Latham & Watkins LLP | Partner | tax | New York |
| Aaron Bernstein | Latham & Watkins LLP | Partner | tax | New York |
| Tessa Young | Latham & Watkins LLP | Associate | tax | Not stated |
| James Aldred | Latham & Watkins LLP | Associate | tax | Not stated |
| Aron Potash | Latham & Watkins LLP | Partner | environmental | Los Angeles |
| Qingyi Pan | Latham & Watkins LLP | Associate | environmental | Not stated |
| Chad Jennings | Latham & Watkins LLP | Counsel | FDA | Washington, D.C. |
| Carolyne Hathaway | Latham & Watkins LLP | Of counsel | FDA | Washington, D.C. |
| Trevor Thompson | Latham & Watkins LLP | Associate | FDA | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | healthcare regulatory | Bay Area |
| Jeffrey Tochner | Latham & Watkins LLP | Partner | intellectual property | New York |
| Pelin Serpin | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | cybersecurity | Bay Area |
| Mitch Bennett | Latham & Watkins LLP | Associate | cybersecurity | Not stated |
| Benjamin Rosemergy | Latham & Watkins LLP | Partner | compensation and benefits | Chicago |
| Joseph Benedetto | Latham & Watkins LLP | Associate | compensation and benefits | Not stated |
21 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 316m (US$316.25 million)
- What the figure measures
- Issue size
- Client
- ANI Pharmaceuticals, Inc.Issuer
- Counterparties
- initial purchasers (Investor)